There were 133 press releases posted in the last 24 hours and 402,830 in the last 365 days.

World Vaccines (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus, HIB, Others) Market Analysis 2018

Dublin, Sept. 17, 2018 (GLOBE NEWSWIRE) -- The "Vaccines 2018: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus, HIB, Others)" report has been added to ResearchAndMarkets.com's offering.

The global market for human vaccines is experiencing strong growth, fuelled by favorable demographics (population growth, rising life expectancy), continued new product introductions, indication expansions for some products and rising usage, particularly in India and China. Vaccines 2018: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments examines the market for vaccines used in humans to prevent various types of disease, providing a comprehensive market summary.

Issues and Trends in the Market

Vaccination has played an enormous role in the prevention of disease, having had the greatest impact on human health of any medical intervention to date. As a result, vaccine-preventable diseases and their resulting deaths are now relatively rare in the developed world. However, the developing nations have not benefited as much from the introduction of vaccines. Additionally, other issues are impacting the vaccines industry both positively and negatively. Vaccines 2018 discusses some of the most important macro and micro trends, including:

  • Rising life expectancy;
  • increasing obesity;
  • growing out of pocket spending on healthcare;
  • health insurance changes in the U.S.;
  • decentralization of healthcare services;
  • austerity programs in Europe;
  • global healthcare mergers and acquisitions;
  • vaccine safety challenges and negative public opinion;
  • vaccine shortages;
  • refusal to vaccinate.

Competitive Landscape

The report also discusses the vaccine businesses of industry leaders as well as emerging players with high potential. Many of the larger companies - some active in other areas in addition to vaccines - are discussed, with a focus on their preventative vaccine businesses and products. (Specifically excluded is discussion of related infectious disease products such as therapeutic vaccines and monoclonal antibodies.)

Key Topics Covered:

1. Executive Summary
The Global Vaccines Industry
Scope and Methodology
Market Estimates and Forecasts

2. Introduction to Vaccines
A Brief History: The Development of Vaccines
The Human Immune System
Vaccine Mechanism of Action
Types of Vaccines
Attenuated (Weakened) Live Viruses
Killed (Inactivated) Viruses
Toxoid Vaccines
Genetically Engineered/Modified Vaccines
Vaccine Approval Process

3. Pediatric Preventative Vaccines
Childhood Immunization in the United States
Childhood Immunization Rates
Challenges to the Vaccine Delivery System
Recommended Childhood Immunization Schedule
State Immunization Recommendations
United Nations Initiatives
Pediatric Vaccine Products
Addiction
BCG
Dengue Fever
Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio
Haemophilus Influenzae Type B
Hand, Foot & Mouth Disease
Hepatitis A
Influenza
Measles, Mumps and Rubella
Meningococcal Disease
Pneumococcal Conjugate
Rotavirus
Respiratory Syncytial Virus
Varicella
Pediatric Vaccines in Development
The World Market for Pediatric Preventive Vaccines
Total Market Size and Forecast
Hepatitis Vaccine Market
Haemophilus Influenzae Type B Vaccine Market
Measles, Mumps and Rubella Vaccines
Combination Vaccines Market
Pneumococcal Vaccine
Poliovirus Vaccine
Varicella Vaccines
Other Pediatric Vaccines

4. Adult Preventative Vaccines
Global Influenza Surveillance Program
U.S. Surveillance
Recommended Adult Immunizations
WHO International Health Regulations
Adult Vaccine Products
BCG
Cervical Cancer
Cholera
Diphtheria-Tetanus
Ebola
Hepatitis
Influenza
Japanese Encephalitis
Nosocomial Infections
Pneumococcal Disease
Rabies
Shingles
Typhoid Fever
Yellow Fever
Adult Vaccines in Development
The World Market for Adult Preventive Vaccines
Total Market Size and Forecast
Cervical Cancer Market
Hepatitis Market
Influenza Vaccine Market
Pneumococcal Vaccine Market
Travel and Other Vaccine Market

5. Total Vaccines Market
Trends Driving the Vaccines Market
Market Size and Forecast
Vaccine Sales by Region
Vaccine Market Competitors
Pediatric Vaccines
Adult Vaccines

6. Issues and Trends
Rising Life Expectancy
Increasing Obesity
Addiction Epidemic
Growing Out of Pocket Spending on Healthcare
Health Insurance Changes in the U.S.
Affordable Care Act Changes
Reimbursement Changes and Value-Based Care
Decentralization of Healthcare Services
Urgent Care Centers
Retail Clinics
Austerity Programs in Europe
UK
Other Nations
Global Healthcare Mergers and Acquisitions
Vaccine Safety
Data
Refusal to Immunize
Post-Licensure Surveillance
The Vaccine Injury Compensation Program
World Health Organization
Other Initiatives
Pricing Pressure
Cost of Vaccines in the United States
Vaccine Shortages
Preventing Shortages in the Developed Countries
Preventing Shortages in Developing Nations
U.S. National Vaccine Plan
Vaccines and Bioterrorism
Project Bioshield Act
National Bio and Agro-Defense Facility
Vaccine Treatment and Evaluation Units
Anthrax
Smallpox
New Disease Threats
Stimulating Vaccine Development
Global Health Vaccine Center of Innovation
Human Vaccines Project
Innovations in Vaccine Delivery Systems
Mucosal Delivery
Intranasal Delivery
Microneedles

7. Company Profiles

  • Bavarian Nordic A/S
  • Bharat Biotech
  • Crucell /Johnson & Johnson
  • CSL Limited
  • Daiichi Sankyo Co. Ltd.
  • Emergent Biosolutions
  • GlaxoSmithKlin
  • Hawaii Biotech
  • Medimmune
  • Merck & Co. Inc.
  • Mymetics
  • PaxVax
  • Pfizer
  • Sanofi Pasteur
  • Serum Institute of India Pvt. Ltd.
  • Soligenix
  • Takeda Pharmaceutical Co. Ltd.
  • Valneva

For more information about this report visit https://www.researchandmarkets.com/research/fn29rr/world_vaccines?w=12

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Cervical Cancer Drugs , Cancer Vaccines, Pediatrics

22157.jpg

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.